UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007893
Receipt number R000009300
Scientific Title Autologous serum eye drops with added hyaluronic acid in the conjunctival sac: a study of the residual time 2
Date of disclosure of the study information 2012/05/14
Last modified on 2023/05/15 10:56:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Autologous serum eye drops with added hyaluronic acid in the conjunctival sac: a study of the residual time 2

Acronym

A study of autologous serum eye drops with added hyaluronic acid 2

Scientific Title

Autologous serum eye drops with added hyaluronic acid in the conjunctival sac: a study of the residual time 2

Scientific Title:Acronym

A study of autologous serum eye drops with added hyaluronic acid 2

Region

Japan


Condition

Condition

keratoconjunctival dysfunction,severe dry eye,late-onset bleb leak after trabeculectomy

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy of hyaluronic acid to prolong the residual time of autologous serum eye drops in the conjunctival sac.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Albumin concentration in the conjunctival sac 5min., 10min., 15min., 20min. after administration of autologous serum eye drops added hyaluronic acid

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Cluster

Blinding

Double blind -all involved are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

apply 10 microliter autologous serum eye drops added hyaluronic acid(autologous serum 50%,hyaleinmini0.3,33%,cravit1.5, 16.7%),1 week,apply 10 microliter autologous serum eye drops added saline(autologous serum 50%,saline 33%,cravit1.5,16.7%)

Interventions/Control_2

apply 10 microliter autologous serum eye drops added saline(autologous serum 50%, saline 33%, cravit1.5, 16.7%), 1 week,
apply 10 microliter autologous serum eye drops added hyaluronic acid (autologous serum 50%,hyaleinmini0.3, 33%,cravit1.5, 16.7%)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

persons without severe keratoconjunctival dysfunction

Key exclusion criteria

paient with severe keratoconjunctival dysfunction

Target sample size

16


Research contact person

Name of lead principal investigator

1st name Hideto
Middle name
Last name Sagara

Organization

Marui Eye Clinic

Division name

Director

Zip code

9750062

Address

1-83-2, Honjinmae Haramachi-ku, Minamisouma, Fukushima 975-0062, Japan.

TEL

0244-25-7488

Email

hide1234@ruby.ocn.ne.jp


Public contact

Name of contact person

1st name Hideto
Middle name
Last name Sagara

Organization

Marui Eye Clinic

Division name

Director

Zip code

9750062

Address

1-83-3, Honjinmae Haramachi-ku, Minamisouma, Fukushima 975-0062, Japan.

TEL

0244-24-0101

Homepage URL


Email

hide1234@ruby.ocn.ne.jp


Sponsor or person

Institute

Marui Eye Clinic

Institute

Department

Personal name



Funding Source

Organization

Marui Eye Clinic

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Marui Eye Clinic

Address

1-83-3, Honjinmae Haramachi

Tel

0244257488

Email

hide1234@ruby.ocn.ne.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 05 Month 14 Day


Related information

URL releasing protocol

Cancellation before examination start

Publication of results

Unpublished


Result

URL related to results and publications

Cancellation before examination start

Number of participants that the trial has enrolled

0

Results

Cancellation before examination start

Results date posted

2023 Year 05 Month 15 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Cancellation before examination start

Participant flow

Cancellation before examination start

Adverse events

Cancellation before examination start

Outcome measures

Cancellation before examination start

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2012 Year 04 Month 01 Day

Date of IRB

2008 Year 03 Month 01 Day

Anticipated trial start date

2012 Year 04 Month 01 Day

Last follow-up date

2020 Year 12 Month 12 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 05 Month 07 Day

Last modified on

2023 Year 05 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009300


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name